| Intermediates | API/End Use | CAS No. | Regulatory Status |
|---|---|---|---|
| 2-Amino-3,5-Dibromo-Benzaldehyde | Ambroxol | 50910-55-9 | Tech Pack |
| Amlodipine Base | AmlodipineBesilate | 88150-42-9 | GMP/Tech Pack |
| Diketone (4 Fluoro-a-[2-methyl-1-oxopropyl]-y, bbisphenylbenzene butaneamide) | Atrovastatin | 125971-96-2 | Tech Pack |
| Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole-2-yl)butanoate | Bendamustin HCl | 3543-73-5 | GMP/Tech Pack |
| 3’-Chloropropiophenone | Bupropion | 34841-35-5 | Tech Pack |
| 1-(4-Methylphenyl)-4,4,4-Trifluoro-butane-1,3-Dione | Celecoxib | 720-94-5 | GMP/Tech Pack |
| 1-(4-Chloro Benzhdryl) Piperazine | Cetirizine | 303-26-4 | GMP/Tech Pack |
| 5-Cyano Phthalide | Citalopram | 82104-74-3 | Tech Pack |
| S-(+) - Methyl-(2-Chlorophenyl)[(2-(2-thienyl)amino | Clopidogrel | 141109-19-5 | GMP/Tech Pack |
| 3,5-Diiodo Salicylic Acid | Closantel / Rafoxanide | 133-91-5 | Tech Pack |
| N-(4-cynophenyl)-glycine | Dabigatran | 42288-26-6 | GMP/Tech Pack |
| 4,6-Dichloro-2-methylpyrimidine | Dasatinib | 1780-26-3 | GMP/Tech Pack |
| 2-[(5-chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester | Edoxaban | 1243308-37-3 | GMP/Tech Pack |
| Ethyl oxalyl chloride | Edoxaban | 125542-74-7 | GMP/Tech Pack |
| 2,3-dihydrobenzo[b][1,4]dioxine-6-carbaldehyde | Eliglustat | 29668-44-8 | GMP/Tech Pack |
| [Ketosulfone] 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl) phenyl]ethanone | Etoricoxib | 221615-75-4 | Tech Pack |
| Iso Thiourea Hcl. (ITU) | Famotidine | 88046-01-9 | Tech Pack |
| N-sulfamyl-3-chloropropionamidine hydrochloride (IF) | Famotidine | 106649-95-0 | Tech Pack |
| Sulfamide | Famotidine | 7803-58-9 | Tech Pack |
| Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | Febuxostat | 160844-75-7 | Tech Pack |
| Fex 10 | Fexofenadine | 154477-55-1 | GMP/Tech Pack |
| Fex 9 | Fexofenadine | 154477-54-0 | GMP/Tech Pack |
| Fex 12 | Fexofenadine | 83799-24-0 | GMP/Tech Pack |
| Azacyclonol | Fexofenadine | 115-46-8 | GMP/Tech Pack |
| 2,4Difluoro 1H,1yl,1,2,4Triazole Acetophenone (DFTA) | Fluconazole | 51336-94-8 | Tech Pack |
| Intermediates | API/End Use | CAS No. | Regulatory Status |
|---|---|---|---|
| Sulphonamide of Glibenclamide | Glibenclamide | 16673-34-0 | GMP/Tech Pack |
| Glimepiride Sulfonamide | Glimepiride | 119018-29-0 | GMP/Tech Pack |
| 4-(2-aminoethyl)benzene sulfonamide | Glipizide | 35303-76-5 | GMP/Tech Pack |
| 3-(N-Methyl-N-Pentyl amino)propionic acid HCl | Ibandronate | 625120-81-2 | GMP/Tech Pack |
| 2-(Chloromethyl)-4-methoxy-3-methylpyridine hydrochlorid | Ilaprazole | 86604-74-2 | GMP/Tech Pack |
| 2,4-Dihydro-4-[4-[4-(4-hydroxyphenyl]-1-piperazinyl]phenyl]-2-(1 methylpropyl)-3H-1,2,4-triazol-3-1 | Itraconazole | 106461-41-0 | GMP/Tech Pack |
| ( Cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-ylmethyl methane sulphonate | Itraconazole | 67914-86-7 | GMP/Tech Pack |
| Cis Bromo Benzoate | Ketoconazole | 61397-56-6 | Tech Pack |
| Diethyl Cyclopropane-1,1-Dcarboxylate | Ketorolac | 1559-02-0 | GMP/Tech Pack |
| 2-(Chloromethyl)-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride (Lansochloro) | Lansoprazole | 127337-60-4 | GMP/Tech Pack |
| lansoprazole crude | Lansoprazole | 103577-45-3 | GMP/Tech Pack |
| 2-mercaptobenzimidazole | Lansoprazole | 583-39-1 | GMP/Tech Pack |
| 2-[[[3-Methyl-4-(222-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzimidazole | Lansoprazole | 103577-40-8 | Tech Pack |
| (-)-1-[4-(Chlorophenyl)phenyl Methyl] piperazine | Levocetirizine | 130018-88-1 | GMP/Tech Pack |
| S(+)-2-Aminobutyramide Hydrochloride (SABAMHCL) | Levocetirizine | 7682-20-4 | GMP/Tech Pack |
| 4-chlorobenzhydryl amine | Levocetirizine | 150700-52-0 | GMP/Tech Pack |
| 2-n-Butyl-4-chloro-5-formyl-1-H-imidazole(BCFI) | Losartan | 83857-96-9 | Tech Pack |
| 1-Acetamido-3,5-dimethyladamantane | Memantine HCl | 19982-07-1 | GMP/Tech Pack |
| Metoprolol Base | Metoprolol | 37350-58-6 | GMP/Tech Pack |
| 1–(2,4-Dichlorophenyl)-2-(1H-Imidazol-1-yl)ethanol | Miconazole | 24155-42-8 | GMP/Tech Pack |
| Trityl olmesartan medoxomil | Olmesartan | 144690-92-6 | GMP/Tech Pack |
| 2-chloromethyl-3 5-dimethyl-4-methoxy pyridine hydrochloride (Omechloro) | Omeprazole | 86604-75-3 | GMP/Tech Pack |
| Intermediates | API/End Use | CAS No. | Regulatory Status |
|---|---|---|---|
| 5-methoxy-2-((4-methoxy-3 5-dimethylpyridin-2-yl)methylthio)-1h-benzimidazole | Omeprazole | 1346599-85-6 | GMP/Tech Pack |
| 1,2,3,9-Tetrahydro-9-methyl-4(H)-Carbazol-4-One | Ondansetron | 27387-31-1 | GMP/Tech Pack |
| 2-Amino-3-benzyloxypyridine | Paliperidone | 24016-03-3 | GMP/Tech Pack |
| N-Methyl Paroxetine | Paroxetine | 110429-36-2 | Tech Pack |
| 3-(Carbamoyl)-5-Methyl Hexanoic Acid | Pregabalin | 181289-33-8 | GMP/Tech Pack |
| Dibenzo[B,F][1,4]-Thiazepin-11(10H)-one | Quetiapine | 3159-07-7 | GMP/Tech Pack |
| Pyridine 4-chloro-2,3-dimethyl) 1- oxide | Rabeprazole | 59886-90-7 | GMP/Tech Pack |
| 2-{[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]methylthio}-1H-benzimidazole (RabeSulphide) | Rabeprazole | 117977-21-6 | GMP/Tech Pack |
| 3-methoxy benzene thiol | Raloxifene | 15570-12-4 | GMP/Tech Pack |
| 2-bromo-4-methoxyacetophenone | Raloxifene | 2632-13-5 | GMP/Tech Pack |
| 6-methoxy-2-(4-methoxyphenyl)benzo [b]thiophene | Raloxifene | 63675-74-1 | GMP/Tech Pack |
| 4-(2-(piperidin-1-yl)ethoxy)benzoic acid hydrochloride | Raloxifene | 84449-80-9 | GMP/Tech Pack |
| NMSM | Ranitidine | 61832-41-5 | GMP/Tech Pack |
| 4-[4-[(5S)-5-Phthalimidomethyl-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone | Rivaroxaban | 446292-08-6 | GMP/Tech Pack |
| 4-(4-aminophenyl)morpholin-3-one | Rivaroxaban | 438056-69-0 | GMP/Tech Pack |
| S)-()-Glycidyl Phthalimide | Rivaroxaban | 161596-47-0 | GMP/Tech Pack |
| 5-Chlorothiophene-2-carboxylic acid | Rivaroxaban | 24065-33-6 | GMP/Tech Pack |
| 4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl] -1-(2,4,5-trifluorophenyl)butan-2-one | Sitagliptin | 764667-65-4 | GMP/Tech Pack |
| 3'2-n-propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)-1H-benzimidazole | Telmisartan | 152628-02-9 | GMP/Tech Pack |
| L-Valine methyl ester hydrochloride | Valsartan | 6306-52-1 | Tech Pack |
| 6-chloro-5-(2-chloro-ethyl)-1 3-dihydro-2H-indol-2-one | Ziprasidone | 118289-55-7 | GMP/Tech Pack |
| 3-(1-Piperazinyl)-1,2-benzisothiazole | Ziprasidone | 87691-87-0 | GMP/Tech Pack |
Our sourcing function is designed to help our clients identify and work with reputable and reliable overseas companies that manufacture the products they require. Whether the product is readily available or needs custom synthesis, we use our in-depth understanding of the production processes and knowledge of the infrastructural and chemical capabilities of different manufacturers to help identify the right candidates for our principles.
Our export function focuses on promoting Indian-made pharmaceutical finished products and raw material to customers in countries across the globe.
